Study uncovers how prostate cancer becomes deadly, offers hope for new treatments
In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how the disease transforms into its most lethal form and identified a promising new treatment strategy.
3 hours ago
0
16

Researchers identify genetic marker that could guide brain cancer treatment
University of Kentucky Markey Cancer Center researchers have discovered a genetic biomarker that could help identify patients with glioblastoma most likely to benefit from the cancer drug bevacizumab.
2 hours ago
0
0

New methods show how fast breast cancers grow and how surgery delays affect cancer staging
Using a novel method to analyze tumor growth rates, researchers at Fox Chase Cancer Center have provided the most in-depth assessment to date of how fast breast cancers grow in patients and how surgical delays may affect ...
5 hours ago
0
0

'Powerful new approach': New drug combination strategy shows promise against hard-to-treat cancers
A potential target for experimental drugs that block PRMT5—a naturally occurring enzyme some tumors rely more on for survival—has been identified by researchers with the Fralin Biomedical Research Institute's Cancer Research ...
5 hours ago
0
0

AI platform designs molecular missiles to attack cancer cells
Precision cancer treatment on a larger scale is moving closer now that researchers have developed an AI platform to tailor protein components and arm the patient's immune cells to fight cancer.
18 hours ago
0
48

Key enzyme in cell migration and tumor metastasis identified
Konstanz researchers identify an enzyme that plays a role in the migration of cells in our body—not only during normal tissue formation and wound healing, but also when tumor cells metastasize. This makes the enzyme an ...
21 hours ago
0
4

Women of African ancestry may be biologically predisposed to early onset or aggressive breast cancers
While the incidence of breast cancer is highest for white women, Black women are more likely to have early-onset or more aggressive subtypes of breast cancer, such as triple-negative breast cancer. Among women under 50, the ...
19 hours ago
0
0

Drug combination shows promising anti-tumor effects on blood cancer cells
Researchers at Uppsala University have identified a promising therapeutic approach for the challenging blood cancer multiple myeloma. In a new preclinical study, they demonstrate that a dual treatment with drugs that inhibit ...
19 hours ago
0
0

At-home melanoma testing: Skin patch test works in mice
Melanoma testing could one day be done at home with a skin patch and test strip with two lines, similar to COVID-19 home tests, according to University of Michigan researchers.
20 hours ago
0
0

Improving colorectal cancer prevention and treatment for Black Americans
Despite being one of the most preventable and treatable cancers, colorectal cancer continues to claim more lives in Black communities than in any other racial group in the United States. Incidence and mortality rates remain ...
21 hours ago
0
0

Study paves path to improved diagnosis, treatment of NUT carcinoma
Dana-Farber research uncovered the potential for underdiagnosis of this aggressive cancer and identified additional tests required for an accurate diagnosis.
21 hours ago
0
0

Blocked fuel source transforms pancreatic tumor environment for enhanced treatment
Cancer cells and tumors do not exist in a vacuum. Far from the isolation and self-sufficiency of the fictional Wakanda, tumors develop in and alter the nearby milieu of immune cells, connective tissue, blood vessels and a ...
23 hours ago
0
0

When should preventive mastectomy be offered for women at higher risk of breast cancer?
More women at higher risk of breast cancer should be offered a mastectomy, according to researchers at Queen Mary and London School of Hygiene and Tropical Medicine.
23 hours ago
0
0

Oxidative stress may suppress cancer onset in individuals with BRCA2 gene variants
Oxidative stress is considered to contribute to the development of cancer. However, a recent study in Japan showed that oxidative stress may suppress rather than cause cancer development in individuals with variants of the ...
23 hours ago
0
0

Research uses AI to find pathologic and genetic basis for worse outcome of endometrial cancer in Black women
Endometrial cancer—in which tumors develop in the inner lining of the uterus—is the most prevalent gynecological cancer in American women, affecting more than 66,000 women a year. Black women are particularly at risk, ...
23 hours ago
0
0

Less is more: Low-dose olanzapine can curb chemo-induced nausea without sedation
Chemotherapy-induced nausea and vomiting are among the most distressing side effects of anti-cancer treatment, particularly for those receiving highly emetogenic regimens such as anthracycline plus cyclophosphamide combinations. ...
23 hours ago
0
0

GLP-1 receptor agonist use linked to lower mortality in seniors with cancer, T2D
For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with lower all-cause mortality than dipeptidyl peptidase-4 inhibitor (DPP4i) use, according to ...
18 hours ago
0
0

From sweetener to cancer fighter? Fermented stevia shows promise in pancreatic cancer study
In an unexpected twist in the fight against cancer, humble kitchen bacteria and a plant best known for sweetening tea could one day help in treating one of humanity's deadliest diseases, new research suggests.
21 hours ago
0
0

Anti-cancer antibody therapies accidentally destroy immune cells, study reveals
Immune checkpoint inhibitors (ICIs), a powerful form of immunotherapy, have revolutionized cancer treatment by unleashing the body's own immune system to fight tumors. These compounds target the programmed cell death-ligand ...
23 hours ago
0
0

Study shows targeting non-cancerous cells can overcome ovarian cancer resistance
In a recent paper published in Nature, researchers at the University of Chicago discovered how to block nicotinamide N-methyl transferase (NNMT), an enzyme that is involved in the progression of high-grade serous ovarian ...
Jul 24, 2025
0
20

New drug strategy blocks cancer cells' adaptation, doubling chemotherapy effectiveness
In a wholly new approach to cancer treatment, Northwestern University biomedical engineers have doubled the effectiveness of chemotherapy in animal experiments.
Jul 23, 2025
0
102

Study finds immune cells undermine cancer therapy by triggering their own death
A team of Memorial Sloan Kettering Cancer Center (MSK) researchers have made an important finding about why genetically engineered immune cells sometimes fail to finish the job when given as a cancer treatment. The new discovery ...
Jul 23, 2025
0
2

Patients' own autoantibodies may hold key to boosting cancer immunotherapy response
A new study has revealed that autoantibodies—immune proteins traditionally associated with autoimmune disease—may profoundly influence how cancer patients respond to immunotherapy.
Jul 23, 2025
0
11
